AstraZeneca PLC AZN-GB:London Stock Exchange

RT Quote | Exchange | GBp
Last | 10/22/21 BST
8,996.00quote price arrow up+133.00 (+1.50%)
52 week range
6,736.00 - 9,081.00
Loading...
  • Open8,892.00
  • Day High9,029.00
  • Day Low8,873.00
  • Prev Close8,863.00
  • 52 Week High9,081.00
  • 52 Week High Date10/12/21
  • 52 Week Low6,736.00
  • 52 Week Low Date03/03/21

Key Stats

  • Market Cap162,894.3M
  • Shares Out1,312.79M
  • 10 Day Average Volume1.26M
  • Dividend202.20
  • Dividend Yield2.25%
  • Beta0.16
  • YTD % Change22.83

KEY STATS

  • Open8,892.00
  • Day High9,029.00
  • Day Low8,873.00
  • Prev Close8,863.00
  • 52 Week High9,081.00
  • 52 Week High Date10/12/21
  • 52 Week Low6,736.00
  • 52 Week Low Date03/03/21
  • Market Cap162,894.3M
  • Shares Out1,312.79M
  • 10 Day Average Volume1.26M
  • Dividend202.20
  • Dividend Yield2.25%
  • Beta0.16
  • YTD % Change22.83

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date08/12/2021
  • Div Amount64.80
  • Split Date-
  • Split Factor-

Profile

MORE
AstraZeneca PLC is a biopharmaceutical company. It focuses on discovery and development of products, which are then manufactured, marketed and sold. It focuses on three main therapy areas: Oncology, Cardiovascular, Renal & Metabolic (CVRM) and Respiratory, while selectively pursuing therapies in Autoimmunity, Infection and Neuroscience. In CVRM, it is expanding its portfolio into the cardiovascular-renal area with roxadustat, as well as investing to explore the benefits of...
Leif Johansson
Non-Executive Chairman
Pascal Soriot
Chief Executive Officer
Aradhana Sarin M.D.
Chief Financial Officer
Ruud Dobber Ph.D.
Executive Vice President
Menelas Pangalos
Executive Vice President
Address
1 Francis Crick Avenue
Cambridge
CB2 0AA
United Kingdom